C.H. Robinson Worldwide Declares Quarterly Cash Dividend
Get Alerts CHRW Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
Revenue Growth %: +20.0%
Join SI Premium – FREE
MINNEAPOLIS--(BUSINESS WIRE)-- C.H. Robinson Worldwide, Inc. (“C.H. Robinson”) (NASDAQ: CHRW) announced that its Board of Directors today declared a regular quarterly cash dividend of 45 cents ($0.45) per share, payable on September 29, 2017, to shareholders of record on September 1, 2017.
C.H. Robinson has distributed regular dividends for more than twenty-five years. As of August 10, 2017, there were approximately 140,325,915 shares outstanding.
About C.H. Robinson
At C.H. Robinson, we believe in accelerating global trade to seamlessly deliver the products and goods that drive the world’s economy. Using the strengths of our knowledgeable people, proven processes and global technology, we help our customers work smarter, not harder. As one of the world’s largest third-party logistics providers (3PL), we provide a broad portfolio of logistics services, fresh produce sourcing and Managed Services for more than 113,000 customers and 107,000 contract carriers through our integrated network of offices and more than 14,000 employees. In addition, the company, our Foundation and our employees contribute millions of dollars annually to a variety of organizations. Headquartered in Eden Prairie, Minnesota, C.H. Robinson (CHRW) has been publicly traded on the NASDAQ since 1997. For more information, visit http://www.chrobinson.com or view our company video.
CHRW-IR
View source version on businesswire.com: http://www.businesswire.com/news/home/20170810006087/en/
C.H. Robinson
Tim Gagnon, Director of Investor Relations
[email protected]
or
Adrienne
Brausen, Investor Relations Associate
[email protected]
Source: C.H. Robinson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees trucking pricing gains ahead despite weak freight demand
- Kiwi Ears KE4 II: Redefining a Modern Classic
- Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share